Thursday, December 5, 2024

Personal Note + Dangers of Cardiac Stents





Up to now, we have had no protocol that removed plaque. This sounds promising.  At least Dr sirus is onside.  My own circulatory system is stable because of vitimin C, but actual plaque removal would be welcome.

right now i am watching and aware.

I want to see if the new administration is able to start pushing changes through.  Resolving circulatory disease is a top priority.  


Personal Note + Dangers of Cardiac Stents

Dr. Sircus



Dec 2


Personal Note: This is a chapter from my book in progress, Natural Cardiology. It highlights a pivotal point, a choice, a fork in the road between the most common heart surgery, with its ‘normal’ inherent dangers and medications, and a new, more natural approach. It is conceded in the field of cardiology that placing stents does not cure atherosclerosis, though they can restore a quality of life.

The new approach, conveniently applied at home, is the ultimate cholesterol chelator. It strips cholesterol right out of the plaque. Cholesterol and calcium are what hold vascular plaque together. 

Five months ago, I was an emergency heart patient determined through a catheterization diagnosis. Two cardiac arteries were almost completely blocked. The doctor said I needed urgent care, but was put on a waiting list. After my sister, who is a nurse, saw my tests, she was surprised they had even let me out of the hospital. However, the doctor went on vacation, and then the hospital went on strike. So, by the time they called me 3 months later, my Natural Allopathic protocol was helping enough for me to ask to be put on the end of the waiting line again.

Then Cavadex came six weeks ago, and after just three weeks into treatment, they called again to put the first stent in. Not only did I decline, but I asked to be taken off the list. I decided this with no doubt or fear. The Cavadex works for me, opening up my circulation and allowing me to exercise increasingly more.

Though approximately 100 million Americans need access to Cavadex, the FDA is blocking its entry. If Kennedy and Trump were serious about making America healthy again, they could start by making Cavadex widely available and get 91 million Americans off of Statin drugs. They could do the same with chlorine dioxide and DMSO. And national campaigns to get the public on magnesium, selenium, and iodine. If these substances were widely used, America’s health would undoubtedly improve.

Will they do this? Probably not, because it would break the back of the pharmaceutical/industrial complex, which depends on people being sick. It will not be easy to facilitate fundamental changes in the world of health and medicine. The experts will disagree with everything that makes sense. Look at all the trouble they are giving Kennedy over water fluoridation.

The FDA uses its power to prevent people from having access to treatments that may help them, but that would not be very profitable, or which might otherwise go against the interests of the agency’s industry benefactors. We witnessed this in the extreme during the past few years, when the FDA and the rest of the regulatory establishment waged war on COVID-19 treatments such as hydroxychloroquine, Ivermectin, and even Vitamins C and D,” writes the Brownstein Institute.





Remchol for home use

CAVADEX® can only be absorbed into the blood stream when administered as an IV or as an enema.
RemChol delivers CAVADEX® via an enema.
Each tube contains CAVADEX® with over 25% absorbed into the blood stream with every treatment.

Remchol tubes can be administered as often as twice a day.

Patients using RemChol report :
Reduction of Angina within 2-4 weeks
Significant reduction of plaque within 2-3 months
No side-effects
Available now




CAVADEX


The story and science of Cavadex

Cavadex reverses heart disease

For over 3 years Cavadex has been saving lives and improving the health of people around the world by reversing heart disease and reducing arterial plaque. Heart disease is the number one killer world-wide and Cavadex is the only treatment that rapidly reduces arterial plaque.
How can we make these claims and where is the science that proves this?

Let me show you......


1. What is Cavadex and how does it reverse heart disease?Cavadex is a ring-shaped starch (cyclodextrin) that circulates around the vascular system absorbing cholesterol from arterial walls and leaves the body intact with the cholesterol inside it via urine.

The cholesterol is sucked out of the arterial plaque and is transported to the kidney’s where the Cavadex (cyclodextrin) containing the cholesterol is excreted via the urine.
Cavadex is not metabolized in the body and has no known side effects.

2. What are the benefits of Cavadex?


Customers using Cavadex report:
Angina starts reducing within weeks.

Reduction in leg cramps when walking.

Reduced calcium scores.

Plaque reduction within months.

Increased memory ability.

More energy.


Cavadex requires no lifestyle changes to be effective.

3. How do you get Cavadex into the blood stream?

The Cavadex cyclodextrin if taken orally is broken down in the stomach and isn’t absorbed into the blood stream intact.

Cholrem has developed an enema that allows absorption via the rectum. This is the only way of absorption besides intravenous injection which is costly and not practical.

Remchol enema tubes contain Cavadex and can be safely self-administered at home.


Remchol box of 32 tubes


4. How do we know Cavadex works?

USA cardiologist Dr. James Roberts MD FACC FAARFM


USA cardiologist Dr. Roberts has been treating his patients for almost 2 years. This is what he has to say about Cavadex.....
"Now that we have Cavadex we can directly remove the plaque"
"Cavadex is directly reversing the arterial disease"
"Cavadex is a universal antidote to atherosclerosis"
"Our patients get better in 2 weeks with Cavadex"
"Rapid onset of biochemical benefit"
"Slow but steady reduction in plaque volume"
"Cavadex improves lower extremity and brain blood flow"
"Cavadex is incredibly safe, you can’t hurt anyone with Cavadex"




Australian Professor Laurie Howes MB BS PhD FRACP FCSANZ


Australian Professor Laurie Howes, head of cardiovascular research at one of Australia’s largest hospitals. Preeminent Consultant Physician (Cardiology) Professor of Pharmacology and Therapeutics at two of Australia’s leading universities This is what he has to say about Cavadex.....
“Cavadex reduces arterial plaque”
"Improving vascular inflammation"
"Cavadex has more safety data than statins when they were introduced"
"Cavadex is one of the greatest medical breakthroughs of our time"
"This is the greatest advance we have had in cardiovascular pharmacology for the treatment of atheroma plaques since statins"



NEWS

Two of our papers have been peer reviewed and published


More papers will be published in the coming months

5. What science supports these claims?

Cholrem development of Cavadex timeline




2013

5a. We know HP-B-CD is safe to use on humans....

A human trial was conducted on twin girls suffering from Niemann-Pick disease.
High dose HP-B-CD was administered via IV for over 2 years to remove cholesterol from cells.
Effects of cyclodextrin in two patients with Niemann–Pick Type C disease



2016

5b. We know HP-B-CD removes arterial plaque from mice....

Scientists from Bonn university, Germany, trialed HP-B-CD on mice with atherosclerosis
and discovered that HP-B-CD substantially reduced the atherosclerotic plaque.
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramminghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878149/


2019

5c. We know HP-B-CD reduces arterial plaque from humans....

After concluding that the science behind HP-B-CD showed that it was safe on humans and HP-B-CD successfully
reduced arterial plaque in mice, Kyle Hodgetts established the company Cholrem Pty Ltd and did
a trial on himself using HP-B-CD to reduce his arterial plaque, resulting in substantial plaque reduction.
2-hydroxypropyl-β-cyclodextrin reduces atherosclerotic plaques in human coronary arteryPeer reviewed published paper - from our 2019 trial


2021

5d. We know Cavadex reduces arterial plaque and improves lipid profile and liver function....

After the success of the first trial, Cholrem Pty Ltd developed a version of HP-B-CD “CAVADEX” and Kyle did a second trial on himself using Cavadex, resulting in substantial lipid reduction, improved liver function and reduced arterial plaque.

Kyle consulted with Australian Professor Laurie Howes MB BS PhD FRACP FCSANZ (Head of cardiovascular research at one of Australia’s largest hospitals. Preeminent Consultant Physician (Cardiology) Professor of Pharmacology and Therapeutics at two of Australia’s leading universities) and the trial results were confirmed.




5e. We know Cavadex is absorbed into the blood stream when administered as an enema....

Cholrem Pty Ltd developed an enema version of Cavadex for home use.

The Remchol enema could supply a 25% absorption rate of Cavadex.



Cholrem Pty Ltd established an online store to commence limited sales of Remchol tubes containing Cavadex.


2022

5f. Cardiologists agree with the science and start treating themselves....

USA cardiologist Dr. James Roberts MD FACC FAARFM trialed Cavadex on himself with similar results.

He then went on and supplied his patients with Remchol tubes.


2023

5g. Patients around the world are reversing their heart disease with Cavadex....

Dr. Roberts reports all patients getting better and that Remchol-Cavadex reduced arterial plaque in his
patients without any adverse side-effects. He also reported several other benefits for stroke patients and brain fog.

Dr. Roberts published his data on his websitehttp://heartfixer.com/Cyclodextrin.htm



5h. The medical industry is starting to speak out about the benefits of Cavadex....
Dr. Roberts agrees to be filmed talking about Cavadex




Professor Laurie Howes reviews all the available data and writes a paperLaurie Letter



5i. Patients start sharing their stories....

Cholrem Pty Ltd establishes the Facebook Cavadex club where customers using Remchol-Cavadex can report their experience and results.

It becomes clear that everyone benefits from Remchol-Cavadex and no adverse side-effects are reported
except some loose stools and very few reports of stomach cramps.

These side effects are concluded to be from the fact that they are using an enema and not from the Cavadex.



2024

5j. Professor Howes puts his name and reputation behind Cavadex....

Prof. Laurie Howes writes a report about Cavadex.

"It will be the greatest therapeutic advance in cardiovascular medicine since the introduction of the statins."Cholrem_Cavadex_Report_l_Howes.pdf



5k. The first time Professor Howes has ever been filmed supporting a product....
Professor Laurie Howes agrees to be filmed talking about Cavadex




5l. The world is finding out that Cavadex works and saves lives....

By July Cholrem has shipped out a total of 12,000 boxes totaling 6,000 orders.



5m. We know Cavadex works because big pharma is now trying to shut us down....

On July 11th FDA issues a warning letter to stop marketing Cavadex


The FDA and Cavadex

On July 11th FDA issues a warning letter to stop marketing Cavadex

We sent back our WARNING LETTER TO THE FDA

We then sent a letter supporting our claims the FDA were acting improperly

Compare latest FDA approved drug for heart disease with Cavadex


Is HP-B-CD safe according to the FDA?

Cyclodextrins are approved by the FDA for various applications and are considered safe.


Is HP-B-CD FDA approved for the treatment of heart disease?

While Cavadex and HP-B-CD are reconised as safe to use, they are not recognized by the FDA as a treatment for heart disease.

Can I get in trouble if I order Cavadex?

No, if the FDA block your order, we will simply reship your order. Most orders are getting through



Why isn’t anyone else developing HP-B-CD as a treatment for heart disease?

When Eicke Latz (the lead scientists that discovered that HP-B-CD reduced arterial plaque in mice in 2016) was asked if they would commence clinical trials on humans, replied..

“Latz estimates it will take approximately EUR 1 million to do the trials. One potential drawback is also one of the most positive aspects of cyclodextrin: the substance, which is a type of sugar, has already been approved by the US Food and Drug Administration for use in humans. But because it has been in existence for some time, it cannot be patented. That makes it harder to get a drug company interested in developing cyclodextrin to treat heart disease, but it also will make it easier to get the drug approved to treat heart disease if the clinic trials support the research findings.”